Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hongcheon Institute of Medicinal Herb (HIMH) is a South Korean research and development organization dedicated to the commercialization of high-value-added products derived from local medicinal plants. Established as a foundation to revitalize the regional bio-industry, the institute specializes in the standardization and efficacy evaluation of botanical extracts for use in functional foods, cosmeceuticals, and natural medicines. HIMH operates comprehensive facilities including chemical analysis labs, efficacy testing centers, and a GMP-certified pilot plant for botanical extraction and formulation. Its research portfolio emphasizes metabolic health, sleep improvement, and immune system support. By providing technical support and technology transfer services, the institute serves as a critical bridge between agricultural production and the global life sciences market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hongcheon Institute of Medicinal Herb.